ORPH - Healthcare names lead premarket gainers

June, 14 2021 08:29 AM Orphazyme A/S

Enochian Biosciences (ENOB) +143% on FDA acceptance of pre-IND request for potential HIV cure.MediaCo Holding (MDIA) +63%.iTeos Therapeutics (ITOS) +52%.Entasis Therapeutics Holdings (ETTX) +25%.Orphazyme A/S (ORPH) +23%.Luokung Technology (LKCO) +22%.Mereo BioPharma Group plc (MREO) +17%.Happiness Biotech Group Limited (HAPP) +16%. on agreement to distribute Volkswagen EV.Metacrine (MTCR) +15%.Corsair Gaming (CRSR) +14%.Senseonics Holdings (SENS) +14%.Carver Bancorp, Inc. (CARV) +12%.Brooklyn ImmunoTherapeutics (BTX) +12% on $125M Novellus Therapeutics deal.Vista Gold Corp. (VGZ) +12%.Xenetic Biosciences, Inc. (XBIO) +10%.Novavax (NVAX) +9% as COVID-19 vaccine shows 90% overall efficacy.Anavex Life Sciences (AVXL) +9% as its ANAVEX®2-73 and ANAVEX®3-71 featured in a new peer-reviewed publication.Broadway Financial Corporation (BYFC) +9%.Riot Blockchain (RIOT) +9%.Lipocine (LPCN) +8% as FDA clears LPCN 1154 IND application.Torchlight Energy Resources (TRCH) +8%.NextGen Acquisition Corp. II (NGCAU) +8%.Marathon Digital Holdings (MARA) +8%.Energy Focus (EFOI) +7% on partnership with FirstEnergy Home and FirstEnergy Advisors.Predictive Oncology (POAI) +7%.

For further details see:

Healthcare names lead premarket gainers

Company Name:	Orphazyme A/S
Stock Symbol:	ORPH
Market:	NASDAQ

Twitter